ASHG, AMP, and Partner Groups Oppose New Bill Allowing Gene Patenting
Share
From The ASHG Blog:
In his testimony, Charles Duan, Director of Technology and Innovation Policy at the R Street Institute, disagreed with Senator Coons’ claims, citing that the draft bill “provides that patent eligibility inheres in any ‘invention or discovery’ that arises ‘through human intervention.’”
Featured Publications
Chevron deference is running on fumes
CFPB Credit Card Late Fee Goes into Effect
Market Gateways, Not the EPA, Determine Power Sector Decarbonization
Artificial Intelligence Legislative Outlook: Spring 2024 Update